MX2010006218A - Compuestos organicos. - Google Patents
Compuestos organicos.Info
- Publication number
- MX2010006218A MX2010006218A MX2010006218A MX2010006218A MX2010006218A MX 2010006218 A MX2010006218 A MX 2010006218A MX 2010006218 A MX2010006218 A MX 2010006218A MX 2010006218 A MX2010006218 A MX 2010006218A MX 2010006218 A MX2010006218 A MX 2010006218A
- Authority
- MX
- Mexico
- Prior art keywords
- organic compounds
- compounds
- salts
- medicines
- preparation
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La presente invención se refiere a compuestos de la fórmula general (I): (ver fórmula (I)) y a las sales de los mismos, de preferencia a las sales farmacéuticamente aceptables de los mismos; en donde R1 tiene el significado explicado en la descripción; a un proceso para su preparación, y al uso de estos compuestos como medicamentos, en especial como inhibidores de renina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122363 | 2007-12-05 | ||
| PCT/EP2008/066747 WO2009071606A1 (en) | 2007-12-05 | 2008-12-04 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010006218A true MX2010006218A (es) | 2010-06-23 |
Family
ID=39203128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010006218A MX2010006218A (es) | 2007-12-05 | 2008-12-04 | Compuestos organicos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8003640B2 (es) |
| EP (1) | EP2229384A1 (es) |
| JP (1) | JP2011506287A (es) |
| KR (1) | KR20100112550A (es) |
| CN (1) | CN101918396A (es) |
| AR (1) | AR069569A1 (es) |
| AU (1) | AU2008333201A1 (es) |
| BR (1) | BRPI0820013A2 (es) |
| CA (1) | CA2705722A1 (es) |
| EA (1) | EA201000882A1 (es) |
| MX (1) | MX2010006218A (es) |
| TW (1) | TW200932241A (es) |
| WO (1) | WO2009071606A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090270380A1 (en) * | 2005-03-31 | 2009-10-29 | Peter Herold | 3,4,5-Substituted Piperidines as Renin Inhibitors |
| WO2009078481A1 (ja) | 2007-12-19 | 2009-06-25 | Dainippon Sumitomo Pharma Co., Ltd. | 二環性へテロ環誘導体 |
| US8658639B2 (en) | 2009-06-24 | 2014-02-25 | Dainippon Sumitomo Pharma Co., Ltd | N-substituted-cyclic amino derivative |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63264573A (ja) * | 1986-04-24 | 1988-11-01 | Toray Ind Inc | 光学活性６−置換−ピリジン−３−カルボン酸エステル化合物および液晶 |
| IL123293A (en) | 1995-09-07 | 2003-06-24 | Hoffmann La Roche | Piperidine derivatives, their preparation and pharmaceutical compositions containing them |
| TW200513461A (en) | 2003-10-01 | 2005-04-16 | Speedel Experimenta Ag | Organische verbindungen |
| AR045950A1 (es) | 2003-10-09 | 2005-11-16 | Speedel Experimenta Ag | Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. |
| TW200613274A (en) | 2004-07-09 | 2006-05-01 | Speedel Experimenta Ag | Organic compounds |
| US20090270380A1 (en) | 2005-03-31 | 2009-10-29 | Peter Herold | 3,4,5-Substituted Piperidines as Renin Inhibitors |
| CA2626568A1 (en) | 2005-10-18 | 2007-04-26 | Nicox S.A. | Renin inhibitors nitroderivatives |
| TW200804359A (en) | 2006-01-19 | 2008-01-16 | Speedel Experimenta Ag | Substituted 4-phenylpiperidines |
| EP1911758A1 (en) * | 2006-10-04 | 2008-04-16 | Speedel Experimenta AG | Phenyl piperidine derivatives for use as renin inhibitors |
-
2008
- 2008-12-03 TW TW097146872A patent/TW200932241A/zh unknown
- 2008-12-04 US US12/745,100 patent/US8003640B2/en not_active Expired - Fee Related
- 2008-12-04 CA CA2705722A patent/CA2705722A1/en not_active Abandoned
- 2008-12-04 EA EA201000882A patent/EA201000882A1/ru unknown
- 2008-12-04 AR ARP080105282A patent/AR069569A1/es unknown
- 2008-12-04 MX MX2010006218A patent/MX2010006218A/es not_active Application Discontinuation
- 2008-12-04 JP JP2010536447A patent/JP2011506287A/ja active Pending
- 2008-12-04 KR KR1020107012384A patent/KR20100112550A/ko not_active Withdrawn
- 2008-12-04 AU AU2008333201A patent/AU2008333201A1/en not_active Abandoned
- 2008-12-04 CN CN200880118754XA patent/CN101918396A/zh active Pending
- 2008-12-04 WO PCT/EP2008/066747 patent/WO2009071606A1/en not_active Ceased
- 2008-12-04 EP EP08858365A patent/EP2229384A1/en not_active Withdrawn
- 2008-12-04 BR BRPI0820013-0A patent/BRPI0820013A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20100303926A1 (en) | 2010-12-02 |
| JP2011506287A (ja) | 2011-03-03 |
| EA201000882A1 (ru) | 2011-02-28 |
| AR069569A1 (es) | 2010-02-03 |
| AU2008333201A1 (en) | 2009-06-11 |
| US8003640B2 (en) | 2011-08-23 |
| WO2009071606A1 (en) | 2009-06-11 |
| KR20100112550A (ko) | 2010-10-19 |
| CA2705722A1 (en) | 2009-06-11 |
| CN101918396A (zh) | 2010-12-15 |
| TW200932241A (en) | 2009-08-01 |
| EP2229384A1 (en) | 2010-09-22 |
| BRPI0820013A2 (pt) | 2015-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| MY149731A (en) | Compounds | |
| GEP20125487B (en) | Organic compounds and their use | |
| MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
| TN2012000248A1 (en) | Novel spiropiperidine compounds | |
| MY184008A (en) | Aryl pyridine as aldosterone synthase inhibitors | |
| TW200613274A (en) | Organic compounds | |
| IN2012DN03182A (es) | ||
| MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
| IN2012DN01292A (es) | ||
| UA99787C2 (en) | Lactams as beta secretase inhibitors | |
| NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
| UA97806C2 (ru) | Бензиламины, способ их получения и их применения в качестве противовоспалительных средств | |
| MX2010006108A (es) | Inhibidores de estearoil-coa-desaturasa. | |
| JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
| WO2011047055A3 (en) | Novel mek inhibitors, useful in the treatment of diseases | |
| WO2010076810A3 (en) | A process for the preparation of gefitinib | |
| MY146671A (en) | Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents | |
| MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
| WO2009126861A3 (en) | Triazolopyridine compounds useful as dgat1 inhibitors | |
| MX2010004235A (es) | Piperidinas tri-sustituidas. | |
| MX2010006218A (es) | Compuestos organicos. | |
| MX2010004505A (es) | Piperidinas 4,4-disustituidas. | |
| WO2012022120A8 (zh) | 二氢吡唑类化合物 | |
| MX2010004759A (es) | Piperidinas 4,4-disustituidas como inhibidoras de renina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |